Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Filings indexed 524 across all filing types
Latest filing 2018-02-08 Earnings Release
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Earnings Release 2017
Earnings Release Classification · 99% confidence The document is titled "Bokslutsrapport" (Year-end Report) and provides detailed financial results for the full year (januari-december 2017) and the fourth quarter (okt-dec 2017), including comprehensive tables covering Net Sales, Operating Profit (EBIT), Net Profit, Cash Flow, and Balance Sheet items. It also includes a CEO commentary summarizing the year's performance and proposing a dividend for the upcoming AGM. This structure is characteristic of a comprehensive annual financial report, which aligns with the definition of an Annual Report (10-K), although the document is in Swedish. Given the comprehensive nature covering the full fiscal year and detailed financial statements, the most appropriate classification is 10-K, despite the local title 'Bokslutsrapport'. It is not merely an Earnings Release (ER) as it contains full financial statements and balance sheet details, nor is it an Interim Report (IR) as it covers the full year. FY 2017
2018-02-08 Swedish
Closing of Biotage’s acquisition of Horizon Technology
M&A Activity Classification · 98% confidence The document is a press release from Biotage AB dated January 16, 2018, announcing the closing of its acquisition of Horizon Technology, Inc. This announcement details a significant corporate transaction (an acquisition) and its financial terms (purchase price). This falls under the category of corporate actions related to mergers, acquisitions, or takeovers. Therefore, the most appropriate classification is 'M&A Activity' (TAR). It is not a standard regulatory filing like 10-K or IR, nor is it a general regulatory announcement (RNS) since it fits a specific category.
2018-01-16 English
Biotage tillträder förvärvet av Horizon Technology
M&A Activity Classification · 98% confidence The document is a press release from Biotage AB, dated January 16, 2018, announcing the completion (closing/settlement) of the acquisition of Horizon Technology Inc. This event involves a significant corporate transaction (M&A) and the associated financing/payment details. According to the definitions, the most fitting category for an announcement regarding a merger proposal or takeover bid completion is 'M&A Activity' (Code: TAR). Although it involves capital structure changes, the primary focus is the finalized acquisition. The document is short and is an announcement, but TAR is more specific than RPA or RNS for M&A news.
2018-01-16 Swedish
Biotage acquires Horizon Technology and strengthens its position in environmental and food safety
M&A Activity Classification · 99% confidence The document is a press release dated December 6, 2017, announcing that Biotage AB has entered into an agreement to acquire Horizon Technology, Inc. This type of announcement, detailing a merger or acquisition proposal, directly corresponds to the definition of M&A Activity (TAR). It is not a full annual report (10-K), an earnings release (ER), or a quarterly report (IR). Since it is a specific announcement about a transaction, it fits best under TAR rather than the general fallback (RNS). The document length (4568 chars) is substantial enough to be the primary announcement, not just a brief notice of publication (RPA).
2017-12-06 English
Biotage förvärvar Horizon Technology och stärker sin position inom miljö och livsmedel
M&A Activity Classification · 99% confidence The document is a press release dated December 6, 2017, announcing that Biotage AB has entered into an agreement to acquire all shares in Horizon Technology Inc. This announcement details the terms of the acquisition (purchase price, financing) and the strategic rationale (strengthening position in environmental and food safety applications). This type of corporate action, specifically a merger or takeover proposal, directly corresponds to the definition of M&A Activity. It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER) as it focuses on a transaction, not periodic financial performance reporting. It is too detailed and specific to be a general Regulatory Filing (RNS) or a Report Publication Announcement (RPA), as it contains substantive news about a major corporate event. Therefore, the most appropriate classification is M&A Activity (TAR).
2017-12-06 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Biotage AB covering the period January-September 2017. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-02 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.